{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T21:49:11Z","timestamp":1761515351629,"version":"build-2065373602"},"reference-count":25,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2005,11,1]],"date-time":"2005-11-01T00:00:00Z","timestamp":1130803200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2005,11,1]],"date-time":"2005-11-01T00:00:00Z","timestamp":1130803200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["aacejournalendocrinepractice.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Endocrine Practice"],"published-print":{"date-parts":[[2005,11]]},"DOI":"10.4158\/ep.11.6.394","type":"journal-article","created":{"date-parts":[[2013,4,5]],"date-time":"2013-04-05T21:38:47Z","timestamp":1365197927000},"page":"394-398","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Unmasking of Type III Hyperlipoproteinemia by Hypothyroidism: A Dramatic Illustration of Altered Lipoprotein Metabolism in a Postpartum Woman"],"prefix":"10.1016","volume":"11","author":[{"given":"Ravi","family":"Retnakaran","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philip W.","family":"Connelly","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeannette","family":"Goguen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.4158\/EP.11.6.394_bb0005","series-title":"The Metabolic and Molecular Bases of Inherited Disease","article-title":"Type III hyperlipoproteinemia (dysbetalipoproteinemia): the role of apolipoprotein E in normal and abnormal lipoprotein metabolism","author":"Mahley","year":"2001"},{"key":"10.4158\/EP.11.6.394_bb0010","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1016\/S0022-2275(20)32417-2","article-title":"Pathogenesis of type III hyperlipoproteinemia (dysbetalipoproteinemia): questions, quandaries, and paradoxes","volume":"40","author":"Mahley","year":"1999","journal-title":"J Lipid Res."},{"key":"10.4158\/EP.11.6.394_bb0015","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1136\/pgmj.75.888.633","article-title":"Unusual presentations to a lipid clinic","volume":"75","author":"Crook","year":"1999","journal-title":"Postgrad Med J."},{"key":"10.4158\/EP.11.6.394_bb0020","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1002\/(SICI)1096-8628(19961016)65:2<149::AID-AJMG14>3.0.CO;2-Q","article-title":"Unusual xanthomas in a young patient with heterozygous familial hypercholesterolemia and type III hyperlipoproteinemia","volume":"65","author":"Feussner","year":"1996","journal-title":"Am J Med Genet."},{"issue":"5 Pt 1","key":"10.4158\/EP.11.6.394_bb0025","doi-asserted-by":"crossref","first-page":"623","DOI":"10.7326\/0003-4819-98-5-623","article-title":"NIH Conference. Type III hyperlipoproteinemia: diagnosis, molecular defects, pathology, and treatment","volume":"98","author":"Brewer","year":"1983","journal-title":"Ann Intern Med."},{"key":"10.4158\/EP.11.6.394_bb0030","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/S0021-9150(99)00212-9","article-title":"Coexisting dysbetalipoproteinemia and familial hypercholesterolemia: clinical and laboratory observations","volume":"148","author":"Carmena","year":"2000","journal-title":"Atherosclerosis."},{"issue":"1 Pt 1","key":"10.4158\/EP.11.6.394_bb0035","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/S0002-8703(99)70262-0","article-title":"Comparison of the hypolipidemic effect of gemfibrozil versus simvastatin in patients with type III hyperlipoproteinemia","volume":"138","author":"Civeira","year":"1999","journal-title":"Am Heart J."},{"year":"1982","series-title":"Lipid and Lipoprotein Analysis: Manual of Laboratory Operation Lipid Research Clinics Program","author":"Civeira","key":"10.4158\/EP.11.6.394_bb0040"},{"key":"10.4158\/EP.11.6.394_bb0045","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1093\/clinchem\/28.6.1379","article-title":"Dextran sulfate-Mg2+ precipitation procedure for quantitation of high-density-lipoprotein cholesterol","volume":"28","author":"Warnick","year":"1982","journal-title":"Clin Chem."},{"key":"10.4158\/EP.11.6.394_bb0050","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/S0022-2275(20)43176-1","article-title":"Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI","volume":"31","author":"Hixson","year":"1990","journal-title":"J Lipid Res."},{"key":"10.4158\/EP.11.6.394_bb0055","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1038\/269604a0","article-title":"Polymorphism of apolipoprotein E and occurrence of dysbetalipoproteinemia in man","volume":"269","author":"Utermann","year":"1977","journal-title":"Nature."},{"key":"10.4158\/EP.11.6.394_bb0060","doi-asserted-by":"crossref","first-page":"5566","DOI":"10.1073\/pnas.81.17.5566","article-title":"Role of apolipoprotein E in the lipolytic conversion of beta-very low density lipoproteins to low density lipoproteins in type III hyperlipoproteinemia","volume":"81","author":"Ehnholm","year":"1984","journal-title":"Proc Natl Acad Sci U S A."},{"key":"10.4158\/EP.11.6.394_bb0065","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1111\/j.1365-2796.1991.tb00428.x","article-title":"Expression of type III hyperlipoproteinaemia in a subject with a secondary hypothyroidism bearing the apolipoprotein E2\/2 phenotype","volume":"230","author":"Feussner","year":"1991","journal-title":"J Intern Med."},{"key":"10.4158\/EP.11.6.394_bb0070","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1136\/pmj.76.892.109","article-title":"A young man with dry skin and nodules on elbows and buttocks","volume":"76","author":"Kashyap","year":"2000","journal-title":"Postgrad Med J."},{"key":"10.4158\/EP.11.6.394_bb0075","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1046\/j.1365-2265.1997.1390964.x","article-title":"Type III hyperlipidaemia with primary hypothyroidism: a unique clinical course of hyperlipidaemia during replacement therapy of thyroid hormone","volume":"46","author":"Kobayashi","year":"1997","journal-title":"Clin Endocrinol (Of)."},{"key":"10.4158\/EP.11.6.394_bb0080","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1016\/0006-291X(90)91568-D","article-title":"Effect of thyroid hormone on hepatic cholesterol 7 alpha hydroxylase, LDL receptor, HMG-CoA reductase, farnesyl pyrophosphate synthetase and apolipoprotein A-I mRNA levels in hypophysectomized rats","volume":"172","author":"Ness","year":"1990","journal-title":"Biochem Biophys Res Commun."},{"key":"10.4158\/EP.11.6.394_bb0085","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1046\/j.1365-2265.2003.01762.x","article-title":"Serum concentrations of remnant-like particles in hypothyroid patients before and after thyroxine replacement","volume":"58","author":"Ito","year":"2003","journal-title":"Clin Endocrinol (Oxf)."},{"key":"10.4158\/EP.11.6.394_bb0090","first-page":"108","article-title":"The magnitude of the hypercholesterolemia of hypothyroidism is associated with variation in the low density lipoprotein receptor gene","volume":"77","author":"Wiseman","year":"1993","journal-title":"J Clin Endocrinol Metab."},{"key":"10.4158\/EP.11.6.394_bb0095","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/S0022-2275(20)35374-8","article-title":"Metabolism of plasma triglycerides in hypothyroidism and hyperthyroidism in man","volume":"22","author":"Abrams","year":"1981","journal-title":"J Lipid Res."},{"key":"10.4158\/EP.11.6.394_bb0100","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1111\/j.1365-2362.1982.tb00690.x","article-title":"Reversal of decreased hepatic lipase and lipoprotein lipase activities after treatment of hypothyroidism","volume":"12","author":"Valdemarsson","year":"1982","journal-title":"Eur J Clin Invest."},{"key":"10.4158\/EP.11.6.394_bb0105","doi-asserted-by":"crossref","first-page":"2591","DOI":"10.1073\/pnas.78.4.2591","article-title":"Defects of receptor-mediated low density lipoprotein catabolism in homozygous familial hypercholesterolemia and hypothyroidism in vivo","volume":"78","author":"Thompson","year":"1981","journal-title":"Proc Natl Acad Sci U S A."},{"key":"10.4158\/EP.11.6.394_bb0110","doi-asserted-by":"crossref","first-page":"34114","DOI":"10.1074\/jbc.M305417200","article-title":"Thyroid hormone regulation and cholesterol metabolism are connected through sterol regulatory element-binding protein-2 (SREBP-2)","volume":"278","author":"Shin","year":"2003","journal-title":"J Biol Chem."},{"key":"10.4158\/EP.11.6.394_bb0115","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1136\/pgmj.63.746.1099","article-title":"Sheehan\u2019s syndrome presenting with type III hyperlipoproteinaemia","volume":"63","author":"Carr","year":"1987","journal-title":"Postgrad Med J."},{"key":"10.4158\/EP.11.6.394_bb0120","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1111\/j.1651-2227.2000.tb00429.x","article-title":"Type III hyperlipoproteinaemia and primary amenorrhoea associated with severe hypothyroidism [letter]","volume":"89","author":"Krsek","year":"2000","journal-title":"Acta Paediatr."},{"key":"10.4158\/EP.11.6.394_bb0125","doi-asserted-by":"crossref","first-page":"22685","DOI":"10.1074\/jbc.272.36.22685","article-title":"Apolipoprotein E2 transgenic rabbits: modulation of the type III hyperlipoproteinemic phenotype by estrogen and occurrence of spontaneous atherosclerosis","volume":"272","author":"Huang","year":"1997","journal-title":"J Biol Chem."}],"container-title":["Endocrine Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X20401211?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X20401211?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/aace.metapress.com\/index\/E7LB9L5YTL20YRVX.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T21:45:48Z","timestamp":1761515148000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1530891X20401211"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,11]]},"references-count":25,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2005,11]]}},"alternative-id":["S1530891X20401211"],"URL":"https:\/\/doi.org\/10.4158\/ep.11.6.394","relation":{},"ISSN":["1530-891X"],"issn-type":[{"type":"print","value":"1530-891X"}],"subject":[],"published":{"date-parts":[[2005,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Unmasking of Type III Hyperlipoproteinemia by Hypothyroidism: A Dramatic Illustration of Altered Lipoprotein Metabolism in a Postpartum Woman","name":"articletitle","label":"Article Title"},{"value":"Endocrine Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.4158\/EP.11.6.394","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2005 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}